Tom Lerch

Tom Lerch earned his Ph.D. from Northwestern University, where he determined crystal structures of protein signaling complexes involved in reproductive health. His postdoctoral research at Oregon Health and Science University elucidated receptor interaction sites on AAV gene therapy vectors. At Pfizer, Tom leads an analytical biochemistry line focused on clinical development of mRNA vaccines, gene therapy vectors, and complex protein therapeutics.